Home
Press Journals
At-Home Drug of Abuse Testing Market Size to Reach $831.9 Million by 2023

At-Home Drug of Abuse Testing Market Size to Reach $831.9 Million by 2023

Published: September 2018

Global at-home DOA testing market is projected to attain a size of $831.9 million by 2023, according to P&S Intelligence.

The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.

Insights into the segments

On the basis of various types of products, the at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers. The market for rapid DOA test kits is expected to witness faster growth during the forecast period, attributed to the increasing adoption of various types of rapid DOA test kits, including test cups and dip cards. Also, these test kits are much cheaper as compared to breath analyzers.

Further, the rapid DOA test kits are bifurcated into test cups, test strips, test dip cards, and other types of kits. Amongst all these, the DOA test cups dominated the global rapid DOA test kits market in 2017. Extensive use of test cups for at-home urine drug testing is a key factor driving the market for this product category.

Samples used for at-home DOA testing are urine, saliva, hair, and other different types of samples. Of these, the products using urine as a sample are expected to witness the fastest growth in the at-home DOA testing market during the forecast period. DOA detection through urine sample is the easiest and most affordable way of at-home DOA testing. It is, therefore, the most commonly used method to analyze the presence of illegal and prescribed drugs in the body.

Browse report overview with 135 tables and 47 figures spread through 168 pages and detailed TOC on "At-Home Drug of Abuse (DOA) Testing Market by Product (Rapid DOA Test Kits [Test Cups, Test Dip Cards, Test Strips], Breath Analyzers), by Sample (Urine, Saliva, Hair), by Geography (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Australia, Brazil, Mexico, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at:https://www.psmarketresearch.com/market-analysis/at-home-doa-testing-market

At-home DOA testing market is projected to witness the fastest growth in Asia-Pacific (APAC)

During the forecast period, the at-home DOA testing market is forecasted to witness the fastest growth in APAC, at a CAGR of 11.0%. This growth is attributed to the rising consumption of illicit drugs in the region. Also, the region is a large producer and trader of illicit drugs, including opium, heroin, amphetamine-type stimulants (ATS), and methamphetamines.

Besides, the limited availability of data on drug abuse within the region has necessitated the development and implementation of government initiatives on drug testing, which in turn, would contribute to the growth of the market in APAC in the coming years. For instance, a number of United Nations Office on Drugs and Crime (UNODC) programs have improved data collection networks, particularly in East and Southeast Asia. However, populous countries, including India and China, in the APAC region face a significant data gap, which requires government intervention. The increasing governments’ initiatives to control drugs abuse lead the growth of the APAC at-home DOA testing market during the forecast period.

Market players are acquiring other firms to increase their market share

The companies operating in the at-home DOA testing industry are acquiring other firms and establishing their presence in different economies to increase their market share. Abbott Laboratories (Abbott) being a major player in the production of at-home DOA testing products acquired Alere Inc. in 2017, to increase its share in the point-of-care testing diagnostics market. The addition of this business aligns with Abbott's strategy for the growth of company and complements the leadership positions across its other businesses, which include medical devices, nutritional supplements, and pharmaceuticals.

Some of the other key players in the at-home DOA testing industry are UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Express Diagnostics Int’l Inc., Assure Tech (Hangzhou) Co. Ltd., Psychemedics Corporation, Confirm BioSciences, Phamatech Inc., Home Health (U.K.) Ltd., and Quest Products Inc.

GLOBAL AT-HOME DOA TESTING MARKET SEGMENTATION

Market Segmentation by Product

Rapid DOA Test Kits
- Test cups
- Test dip cards
- Test strips
- Others
Breath Analyzers

Market Segmentation by Sample

Urine
Saliva
Hair
Others

Market Segmentation by Geography

North America At-Home DOA Testing Market
- By product
- By sample
- By country
  - U.S. at-home DOA testing market
    - By product
    - By sample
  - Canada at-home DOA testing market
    - By product
    - By sample
Europe At-Home DOA Testing Market
- By product
- By sample
- By country
  - U.K. at-home DOA testing market
    - By product
    - By sample
  - Germany at-home DOA testing market
    - By product
    - By sample
  - France at-home DOA testing market
    - By product
    - By sample
  - Italy at-home DOA testing market
    - By product
    - By sample
APAC At-Home DOA Testing Market
- By product
- By sample
- By country
  - China at-home DOA testing market
    - By product
    - By sample
  - Japan at-home DOA testing market
    - By product
    - By sample
  - India at-home DOA testing market
    - By product
    - By sample
  - Australia at-home DOA testing market
    - By product
    - By sample
Latin America (LATAM) At-Home DOA Testing Market
- By product
- By sample
- By country
  - Brazil at-home DOA testing market
    - By product
    - By sample
  - Mexico at-home DOA testing market
    - By product
    - By sample
Middle East and Africa (MEA) At-Home DOA Testing Market
- By product
- By sample
- By country – South Africa, and Rest of MEA